Ascendis Pharma A/S
YORVIPATH
PTH-related disorders
Resolved
187days ago
Catalyst readout · Jan 1, 2026
What's at stake
A key catalyst for YORVIPATH (PTH-related disorders) is expected Jan 1, 2026.
Primary source
· SEC 6-K
verified 13h ago
“Ongoing label expansion trials through PaTHway60 (adults) and PaTHway Adolescent.”